awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38457554-85C0B8BF-C2B4-49D0-A1FC-A8C6A33D61CA
Q38457554-85C0B8BF-C2B4-49D0-A1FC-A8C6A33D61CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38457554-85C0B8BF-C2B4-49D0-A1FC-A8C6A33D61CA
Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events.
P2860
Q38457554-85C0B8BF-C2B4-49D0-A1FC-A8C6A33D61CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38457554-85C0B8BF-C2B4-49D0-A1FC-A8C6A33D61CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69155d5c533c1c37b80a96447cd142e57727df49
P2860
Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.